The C-174G promoter polymorphism of the IL-6 gene affects energy expenditure and insulin sensitivity

Diabetes

Volumn 52, Issue 2, 2003, Pages 558-561

  Kubaszek, Agata ^a   Pihlajamäki, Jussi ^a   Punnonen, Kari ^a   Karhapää, Pauli ^a   Vauhkonen, Ilkka ^a   Laakso, Markku ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; INTERLEUKIN 6; ISOPROTEIN; PROTEIN C 174G; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CALORIMETRY; CYTOKINE PRODUCTION; ENERGY EXPENDITURE; FEMALE; FINLAND; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TRANSPORT SYSTEM; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; HYPERINSULINEMIA; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATION KINETICS; POPULATION RESEARCH; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RISK FACTOR; STATISTICAL SIGNIFICANCE; TISSUE SPECIFICITY;

BLOOD GLUCOSE; CALORIMETRY; ENERGY METABOLISM; FASTING; FEMALE; GENOTYPE; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HETEROZYGOTE DETECTION; HUMANS; HYPERINSULINISM; INFUSIONS, INTRAVENOUS; INSULIN; INTERLEUKIN-6; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); REGRESSION ANALYSIS;

EID: 0037312898     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.2.558     Document Type: Article

References (22)

1. Wallenius V, Wallenius K, Ahren B, Rudling M, Carlsten H, Dickson SL, Ohlsson C, Jansson JO: Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 8:75-79, 2002
2. Terry CF, Loukaci V, Green FR: Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 275:18138-18144, 2000
3. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P: The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102:1369-1376, 1998
4. Hulkkonen J, Pertovaara M, Antonen J, Pasternack A, Hurme M: Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjogren's syndrome and correlate with the clinical manifestations of the disease. Rheumatology 40:656-661, 2001
5. Fernandez-Real JM, Broch M, Vendrell J, Gutierrez C, Casamitjana R, Pugeat M, Richart C, Ricart W: Interleukin-6 gene polymorphism and insulin sensitivity. Diabetes 49:517-520, 2000
6. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, Coppack SW: Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 82:4196-4200, 1997
7. Plata-Salaman CR: Central nervous system mechanisms contributing to the cachexia-anorexia syndrome. Nutrition 16:1009-1012, 2000
8. Tsigos C, Papanicolaou DA, Defensor R, Mitsiadis CS, Kyrou I, Chrousos GP: Dose effects of recombinant human interleukin-6 on pituitary hormone secretion and energy expenditure. Neuroendocrinology 66:54-62, 1997
9. Torpy DJ, Papanicolaou DA, Lotsikas AJ, Wilder RL, Chrousos GP, Pillemer SR: Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6: a pilot study in fibromyalgia. Arthritis Rheum 43:872-880, 2000
10. Fernandez-Real JM, Vayreda M, Richart C, Gutierrez C, Broch M, Vendrell J, Ricart W: Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab 86:1154-1159, 2001
11. Papanicolaou DA, Petrides JS, Tsigos C, Bina S, Kalogeras KT, Wilder R, Gold PW, Deuster PA, Chrousos GP: Exercise stimulates interleukin-6 secretion: inhibition by glucocorticoids and correlation with catecholamines. Am J Physiol 271:E601-E605, 1996
12. Marz P, Cheng JG, Gadient RA, Patterson PH, Stoyan T, Otten U, Rose-John S: Sympathetic neurons can produce and respond to interleukin 6. Proc Natl Acad Sci U S A 95:3251-3256, 1998
13. Stouthard JM, Romijn JA, Van der Poll T, Endert E, Klein S, Bakker PJ, Veenhof CH, Sauerwein HP: Endocrinologic and metabolic effects of interleukin-6 in humans. Am J Physiol 268:E813-E819, 1995
14. Simonsen L, Bulow J, Madsen J, Christensen NJ: Thermogenic response to epinephrine in the forearm and abdominal subcutaneous adipose tissue. Am J Physiol 263:E850-E855, 1992
15. Gardner JD, Rothwell NJ, Luheshi GN: Leptin affects food intake via CRF-receptor-mediated pathways. Nat Neurosci 1:103, 1998
16. Rosenbaum M, Murphy EM, Heymsfield SB, Matthews DE, Leibel RL: Low dose leptin administration reverses effects of sustained weight-reduction on energy expenditure and circulating concentrations of thyroid hormones. J Clin Endocrinol Metab 87:2391-2394, 2002
17. Ravussin E, Lillioja S, Knowler WC, Christin L, Freymond D, Abbott WG, Boyce V, Howard BV, Bogardus C: Reduced rate of energy expenditure as a risk factor for body-weight gain. N Engl J Med 318:467-472, 1988
18. Schwartz MW, Baskin DG, Kaiyala KJ, Woods SC: Model for the regulation of energy balance and adiposity by the central nervous system. Am J Clin Nutr 69:584-596, 1999
19. Haffner SM, Karhapää P, Mykkänen L, Laakso M: Insulin resistance, body fat distribution, and sex hormones in men. Diabetes 43:212-219, 1994
20. Vauhkonen I, Niskanen L, Vanninen E, Kainulainen S, Uusitupa M, Laakso M: Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited. Metabolic studies on offspring of diabetic probands. J Clin Invest 101:86-96, 1998
21. Pihlajamäki J, Karjalainen L, Karhapää P, Vauhkonen I, Laakso M: Impaired free fatty acid suppression during hyperinsulinemia is a characteristic finding in familial combined hyperlipidemia but insulin resistance is observed only in hypertriglyceridemic patients. Arterioscler Thromb Vasc Biol 20:164-170, 2000
22. Laakso M, Malkki M, Kekalainen P, Kuusisto J, Deeb SS: Insulin receptor substrate-1 variants in non-insulin-dependent diabetes. J Clin Invest 94:1141-1146, 1994